Goldman Sachs
TNDM icon

Goldman Sachs’s Tandem Diabetes Care TNDM Stock Holding History

Goldman Sachs’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,700
Closed -$409K – 7257
2016
Q1 		$409K Buy
+4,700
New +$411K ﹤0.01% 4957
2015
Q4 		– Sell
-5,840
Closed -$515K – 7342
2015
Q3 		$515K Buy
+5,840
New +$680K ﹤0.01% 5113
2015
Q1 		– Sell
-10,000
Closed -$1.27M – 7287
2014
Q4 		$1.27M Buy
+10,000
New +$1.39M ﹤0.01% 4312

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Goldman Sachs's TNDM Position: Q2 2026 in Review

Goldman Sachs reduced its Tandem Diabetes Care (TNDM) stake by 61% in Q2 2026, selling an estimated $23.7M and leaving 862,301 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #3025.

Goldman Sachs first reported a position in TNDM in Q4 2013 and has held it in 41 quarters since. The position peaked at $140M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Goldman Sachs held 862,301 shares of Tandem Diabetes Care worth $13M as of Q2 2026.
  • Goldman Sachs sold 1,356,621 Tandem Diabetes Care shares in Q2 2026, an estimated $23.7M.
  • Tandem Diabetes Care made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3025 holding.
  • Goldman Sachs first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 41 quarters since.
  • Goldman Sachs's Tandem Diabetes Care position peaked at $140M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.